Gilead Sciences (GILD)
Gilead Sciences on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).
20.3M
Short interest
settlement 2026-10-15
3.7
Days to cover
+0.4 days vs prior
52.9%
Short share of volume
2026-10-28
1,997
Fails to deliver
settlement 2026-09-15
Thu 29 Oct
Next earnings
estimated date
-$15.9M
Insider flow, 90 days
0 buys, 26 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in GILD is 20,270,007 shares, up 1,965,132 shares over the last month. Over the last 48 readings it ranged from 15,804,496 shares (15 October 2025) to 25,725,417 shares (29 May 2026). At the reported average volume of 5.5M shares a day that is 3.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/gild" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 20,270,007 | -7.1% | 5,454,083 | 3.72 |
| 2026-09-30 | 21,828,725 | +19.3% | 6,503,853 | 3.36 |
| 2026-09-15 | 18,304,875 | -20.4% | 5,017,110 | 3.65 |
| 2026-08-31 | 23,007,029 | -0.8% | 5,438,943 | 4.23 |
| 2026-08-14 | 23,183,970 | -4.9% | 7,146,553 | 3.24 |
| 2026-07-31 | 24,385,621 | -3.5% | 6,312,993 | 3.86 |
| 2026-07-15 | 25,261,911 | -0.9% | 6,888,646 | 3.67 |
| 2026-06-30 | 25,484,358 | +6.8% | 9,596,162 | 2.66 |
| 2026-06-15 | 23,861,932 | -7.2% | 8,868,841 | 2.69 |
| 2026-05-29 | 25,725,417 | +11.2% | 6,740,926 | 3.82 |
| 2026-05-15 | 23,135,379 | +0.4% | 6,501,415 | 3.56 |
| 2026-04-30 | 23,051,059 | +1.3% | 5,681,363 | 4.06 |
| 2026-04-15 | 22,751,109 | +5.7% | 4,803,620 | 4.74 |
| 2026-03-31 | 21,524,970 | +7.7% | 6,659,884 | 3.23 |
| 2026-03-13 | 19,985,404 | +8.3% | 5,945,110 | 3.36 |
| 2026-02-27 | 18,454,950 | -15.7% | 6,745,011 | 2.74 |
| 2026-02-13 | 21,892,924 | -7.6% | 8,417,817 | 2.60 |
| 2026-01-30 | 23,684,789 | +3.1% | 9,218,456 | 2.57 |
| 2026-01-15 | 22,974,646 | -0.8% | 6,098,981 | 3.77 |
| 2025-12-31 | 23,154,890 | +7.0% | 6,326,979 | 3.66 |
| 2025-12-15 | 21,650,110 | +17.1% | 6,783,914 | 3.19 |
| 2025-11-28 | 18,479,939 | +8.7% | 7,394,434 | 2.50 |
| 2025-11-14 | 17,007,031 | -5.4% | 7,329,337 | 2.32 |
| 2025-10-31 | 17,975,927 | +13.7% | 7,065,409 | 2.54 |
| 2025-10-15 | 15,804,496 | -12.4% | 7,648,238 | 2.07 |
| 2025-09-30 | 18,035,549 | -1.2% | 7,429,719 | 2.43 |
| 2025-09-15 | 18,249,455 | +3.9% | 6,855,608 | 2.66 |
| 2025-08-29 | 17,562,109 | -3.6% | 5,089,106 | 3.45 |
| 2025-08-15 | 18,227,408 | -8.8% | 7,206,205 | 2.53 |
| 2025-07-31 | 19,990,775 | -11.3% | 5,369,876 | 3.72 |
| 2025-07-15 | 22,539,960 | +7.4% | 5,764,110 | 3.91 |
| 2025-06-30 | 20,991,552 | -8.7% | 10,217,328 | 2.05 |
| 2025-06-13 | 22,993,007 | +9.8% | 7,973,032 | 2.88 |
| 2025-05-30 | 20,937,020 | -15.2% | 7,616,799 | 2.75 |
| 2025-05-15 | 24,676,861 | +4.7% | 9,578,497 | 2.58 |
| 2025-04-30 | 23,574,395 | +17.4% | 8,770,185 | 2.69 |
| 2025-04-15 | 20,079,194 | -6.1% | 10,598,627 | 1.89 |
| 2025-03-31 | 21,390,611 | -4.3% | 10,485,483 | 2.04 |
| 2025-03-14 | 22,340,679 | -1.1% | 10,554,066 | 2.12 |
| 2025-02-28 | 22,579,856 | +6.7% | 8,448,426 | 2.67 |
| 2025-02-14 | 21,162,249 | -7.7% | 8,295,400 | 2.55 |
| 2025-01-31 | 22,930,560 | -8.9% | 7,078,455 | 3.24 |
| 2025-01-15 | 25,167,786 | -1.9% | 6,425,204 | 3.92 |
| 2024-12-31 | 25,656,042 | +16.7% | 6,455,207 | 3.97 |
| 2024-12-13 | 21,977,968 | -6.1% | 7,090,005 | 3.10 |
| 2024-11-29 | 23,413,412 | +29.6% | 6,087,358 | 3.85 |
| 2024-11-15 | 18,059,419 | +1.8% | 8,490,239 | 2.13 |
| 2024-10-31 | 17,744,662 | +7.7% | 5,268,150 | 3.37 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of GILD volume is 52.9%, up 5.9 points over the last five sessions. Over the last 30 readings it ranged from 23.3% (24 September 2026) to 61.1% (26 October 2026). The latest reading is 8.2 points above the 30-session average of 44.7%, on 1.7M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 907K | 1.7M | 52.9% | 10,736 |
| 2026-10-27 | 950K | 1.9M | 50.4% | 0 |
| 2026-10-26 | 1.5M | 2.5M | 61.1% | 2,074 |
| 2026-10-23 | 1.1M | 2.0M | 51.7% | 1,044 |
| 2026-10-22 | 913K | 2.4M | 38.6% | 668 |
| 2026-10-21 | 979K | 2.1M | 47.0% | 92 |
| 2026-10-20 | 887K | 2.0M | 43.4% | 500 |
| 2026-10-19 | 922K | 2.0M | 45.5% | 5,181 |
| 2026-10-16 | 776K | 2.0M | 39.2% | 1,901 |
| 2026-10-15 | 1.1M | 2.3M | 49.5% | 10,414 |
| 2026-10-14 | 981K | 2.2M | 45.1% | 15,178 |
| 2026-10-13 | 549K | 1.5M | 36.8% | 466 |
| 2026-10-12 | 567K | 1.3M | 45.1% | 2,551 |
| 2026-10-09 | 725K | 1.4M | 50.4% | 4,449 |
| 2026-10-08 | 759K | 1.6M | 48.1% | 5,938 |
| 2026-10-07 | 803K | 1.4M | 56.5% | 5,964 |
| 2026-10-06 | 540K | 1.3M | 43.0% | 3,370 |
| 2026-10-05 | 733K | 1.4M | 51.1% | 1,634 |
| 2026-10-02 | 710K | 1.4M | 51.6% | 100 |
| 2026-10-01 | 581K | 1.4M | 41.2% | 14 |
| 2026-09-30 | 529K | 1.4M | 38.9% | 755 |
| 2026-09-29 | 524K | 1.6M | 33.3% | 3,457 |
| 2026-09-28 | 490K | 1.7M | 29.0% | 15,265 |
| 2026-09-25 | 497K | 1.9M | 26.2% | 6,984 |
| 2026-09-24 | 492K | 2.1M | 23.3% | 112 |
| 2026-09-23 | 555K | 1.5M | 37.5% | 3,470 |
| 2026-09-22 | 647K | 1.5M | 42.3% | 14,385 |
| 2026-09-21 | 1.1M | 2.0M | 54.6% | 15,642 |
| 2026-09-18 | 1.3M | 2.7M | 50.1% | 13,389 |
| 2026-09-17 | 1.2M | 2.1M | 57.3% | 6,811 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 15 September 2026, the fails-to-deliver balance in GILD is 1,997 shares, up 697 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (29 April 2026) to 29,318 shares (3 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-15 | 1,997 | $146.41 | $292K |
| 2026-09-10 | 1,300 | $145.65 | $189K |
| 2026-09-08 | 100 | $151.00 | $15K |
| 2026-08-24 | 2,100 | $146.12 | $307K |
| 2026-08-11 | 701 | $133.06 | $93K |
| 2026-08-10 | 278 | $133.21 | $37K |
| 2026-08-06 | 40 | $131.76 | $5K |
| 2026-08-04 | 27 | $131.15 | $4K |
| 2026-08-03 | 29,318 | $130.21 | $3.8M |
| 2026-07-30 | 199 | $132.73 | $26K |
| 2026-07-22 | 179 | $130.28 | $23K |
| 2026-07-20 | 121 | $134.28 | $16K |
| 2026-07-15 | 24 | $130.04 | $3K |
| 2026-07-14 | 473 | $131.40 | $62K |
| 2026-07-09 | 6,972 | $135.82 | $947K |
| 2026-07-06 | 1,029 | $131.27 | $135K |
| 2026-07-02 | 351 | $125.97 | $44K |
| 2026-06-22 | 39 | $123.76 | $5K |
| 2026-06-12 | 2 | $125.87 | $252 |
| 2026-06-10 | 4 | $125.50 | $502 |
| 2026-06-08 | 4 | $129.16 | $517 |
| 2026-06-03 | 7,392 | $127.57 | $943K |
| 2026-05-19 | 915 | $129.67 | $119K |
| 2026-05-18 | 104 | $129.58 | $13K |
| 2026-05-12 | 7,252 | $133.52 | $968K |
| 2026-05-11 | 21,146 | $131.33 | $2.8M |
| 2026-05-08 | 13,968 | $134.06 | $1.9M |
| 2026-05-07 | 976 | $136.30 | $133K |
| 2026-05-04 | 6,552 | $131.65 | $863K |
| 2026-04-29 | 2 | $129.26 | $259 |
Insider trades
SEC Form 4, newest first. JSONInsiders at GILD reported 26 open-market sells worth $15.9M in the last 90 days and no open-market buys. Latest filing: Mercier Johanna (Chief Comm & Corp Aff Officer) on 2026-10-15.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3K | $156.22 | $469K | 114K |
| 2026-10-15 | Dickinson Andrew D | Chief Financial Officer | Sell | 3K | $156.22 | $469K | 161K |
| 2026-10-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 3K | $148.63 | $446K | 567K |
| 2026-10-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 12K | $147.72 | $1.8M | 570K |
| 2026-09-22 | Burkhart Erin | SVP, Controllership | Tax withholding | 768 | $152.67 | $117K | 1K |
| 2026-09-22 | Burkhart Erin | SVP, Controllership | Exercise or conversion | 2K | price not stated in the filing | not stated | 2K |
| 2026-09-15 | Dickinson Andrew D | Chief Financial Officer | Sell | 3K | $145.29 | $436K | 164K |
| 2026-09-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 600 | $145.29 | $87K | 117K |
| 2026-09-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 800 | $144.46 | $116K | 117K |
| 2026-09-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 2K | $143.69 | $230K | 118K |
| 2026-09-10 | Mercier Johanna | Chief Comm & Corp Aff Officer | Tax withholding | 1K | $144.81 | $195K | 120K |
| 2026-09-10 | Mercier Johanna | Chief Comm & Corp Aff Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 121K |
| 2026-09-10 | O'Day Daniel Patrick | Chairman & CEO | Tax withholding | 4K | $144.81 | $613K | 582K |
| 2026-09-10 | O'Day Daniel Patrick | Chairman & CEO | Exercise or conversion | 9K | price not stated in the filing | not stated | 586K |
| 2026-09-10 | Dickinson Andrew D | Chief Financial Officer | Tax withholding | 1K | $144.81 | $195K | 167K |
| 2026-09-10 | Dickinson Andrew D | Chief Financial Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 168K |
| 2026-09-10 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Tax withholding | 285 | $144.81 | $41K | 9K |
| 2026-09-10 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Exercise or conversion | 590 | price not stated in the filing | not stated | 9K |
| 2026-09-10 | Berger Dietmar | Chief Medical Officer | Tax withholding | 263 | $144.81 | $38K | 20K |
| 2026-09-10 | Berger Dietmar | Chief Medical Officer | Exercise or conversion | 533 | price not stated in the filing | not stated | 20K |
| 2026-09-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 5K | $149.38 | $808K | 577K |
| 2026-09-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 8K | $148.36 | $1.2M | 583K |
| 2026-09-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 2K | $147.51 | $236K | 591K |
| 2026-08-26 | WELTERS ANTHONY | Director | Sell | 7K | $148.82 | $1.0M | 13K |
| 2026-08-26 | WELTERS ANTHONY | Director | Sell | 3K | $148.24 | $504K | 20K |
| 2026-08-26 | WELTERS ANTHONY | Director | Exercise or conversion | 10K | $61.35 | $631K | 23K |
| 2026-08-26 | WELTERS ANTHONY | Director | Sell | 5K | $148.82 | $685K | 13K |
| 2026-08-26 | WELTERS ANTHONY | Director | Sell | 3K | $148.31 | $462K | 17K |
| 2026-08-26 | WELTERS ANTHONY | Director | Exercise or conversion | 8K | $60.67 | $468K | 21K |
| 2026-08-20 | Bluestone Jeffrey | Director | Sell | 335 | $146.26 | $49K | 10K |
| 2026-08-20 | Bluestone Jeffrey | Director | Exercise or conversion | 335 | $61.35 | $21K | 10K |
| 2026-08-20 | Bluestone Jeffrey | Director | Sell | 26 | $146.36 | $4K | 10K |
| 2026-08-20 | Bluestone Jeffrey | Director | Exercise or conversion | 26 | $67.45 | $2K | 10K |
| 2026-08-20 | Bluestone Jeffrey | Director | Sell | 2K | $145.73 | $242K | 10K |
| 2026-08-20 | Bluestone Jeffrey | Director | Exercise or conversion | 2K | $67.45 | $112K | 12K |
| 2026-08-20 | Bluestone Jeffrey | Director | Sell | 2K | $144.92 | $263K | 10K |
| 2026-08-20 | Bluestone Jeffrey | Director | Exercise or conversion | 2K | $67.45 | $122K | 12K |
| 2026-08-20 | Bluestone Jeffrey | Director | Sell | 1K | $143.75 | $167K | 10K |
| 2026-08-20 | Bluestone Jeffrey | Director | Exercise or conversion | 1K | $67.45 | $79K | 11K |
| 2026-08-17 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 11K | $138.04 | $1.6M | 118K |
| 2026-08-17 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 17K | $137.37 | $2.3M | 130K |
| 2026-08-17 | Mercier Johanna | Chief Comm & Corp Aff Officer | Exercise or conversion | 2K | $72.34 | $137K | 146K |
| 2026-08-17 | Mercier Johanna | Chief Comm & Corp Aff Officer | Exercise or conversion | 23K | $66.64 | $1.5M | 144K |
| 2026-08-17 | Dickinson Andrew D | Chief Financial Officer | Sell | 3K | $138.36 | $415K | 166K |
| 2026-08-10 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Tax withholding | 3K | $133.06 | $387K | 8K |
| 2026-08-10 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Exercise or conversion | 6K | price not stated in the filing | not stated | 11K |
| 2026-08-03 | O'Day Daniel Patrick | Chairman & CEO | Sell | 600 | $131.34 | $79K | 592K |
| 2026-08-03 | O'Day Daniel Patrick | Chairman & CEO | Sell | 8K | $130.80 | $1.0M | 593K |
| 2026-08-03 | O'Day Daniel Patrick | Chairman & CEO | Sell | 7K | $129.66 | $869K | 600K |
| 2026-07-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3K | $129.92 | $390K | 121K |
| 2026-07-15 | Dickinson Andrew D | Chief Financial Officer | Sell | 3K | $129.93 | $390K | 169K |
| 2026-07-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 3K | $127.08 | $394K | 607K |
| 2026-07-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 12K | $126.09 | $1.5M | 610K |
| 2026-06-15 | Dickinson Andrew D | Chief Financial Officer | Sell | 3K | $125.40 | $376K | 172K |
| 2026-06-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 1K | $124.00 | $133K | 125K |
| 2026-06-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 450 | $125.40 | $56K | 124K |
| 2026-06-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 1K | $123.42 | $183K | 126K |
| 2026-06-10 | O'Day Daniel Patrick | Chairman & CEO | Exercise or conversion | 9K | price not stated in the filing | not stated | 626K |
| 2026-06-10 | O'Day Daniel Patrick | Chairman & CEO | Tax withholding | 4K | $121.48 | $512K | 622K |
| 2026-06-10 | Mercier Johanna | Chief Comm & Corp Aff Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 129K |
| 2026-06-10 | Mercier Johanna | Chief Comm & Corp Aff Officer | Tax withholding | 1K | $121.48 | $163K | 127K |
| 2026-06-10 | Dickinson Andrew D | Chief Financial Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 176K |
| 2026-06-10 | Dickinson Andrew D | Chief Financial Officer | Tax withholding | 1K | $121.48 | $163K | 175K |
| 2026-06-10 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Exercise or conversion | 589 | price not stated in the filing | not stated | 6K |
| 2026-06-10 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Tax withholding | 283 | $121.48 | $34K | 5K |
| 2026-06-10 | Berger Dietmar | Chief Medical Officer | Exercise or conversion | 533 | price not stated in the filing | not stated | 20K |
| 2026-06-10 | Berger Dietmar | Chief Medical Officer | Tax withholding | 263 | $121.48 | $32K | 19K |
| 2026-06-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 1K | $132.97 | $138K | 618K |
| 2026-06-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 3K | $132.22 | $405K | 619K |
| 2026-06-01 | O'Day Daniel Patrick | Chairman & CEO | Sell | 11K | $131.10 | $1.4M | 622K |
| 2026-05-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 700 | $132.75 | $93K | 126K |
| 2026-05-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 8K | $132.23 | $1.1M | 126K |
| 2026-05-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 11K | $131.19 | $1.5M | 135K |
| 2026-05-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 8K | $130.29 | $1.0M | 146K |
| 2026-05-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Exercise or conversion | 25K | $66.64 | $1.7M | 154K |
| 2026-05-15 | Dickinson Andrew D | Chief Financial Officer | Sell | 3K | $132.27 | $397K | 173K |
| 2026-04-30 | Horning Sandra | Director | Grant | 1K | $0.00 | $0 | 6K |
| 2026-04-30 | MANWANI HARISH | Director | Tax withholding | 224 | $130.84 | $29K | 15K |
| 2026-04-30 | MANWANI HARISH | Director | Grant | 1K | $0.00 | $0 | 15K |
| 2026-04-30 | Rodriguez Javier | Director | Grant | 1K | $0.00 | $0 | 13K |
| 2026-04-30 | WELTERS ANTHONY | Director | Grant | 1K | $0.00 | $0 | 13K |
| 2026-04-30 | LOVE TED W | Director | Grant | 1K | $0.00 | $0 | 5K |
| 2026-04-30 | Bluestone Jeffrey | Director | Grant | 1K | $0.00 | $0 | 10K |
| 2026-04-30 | BARTON JACQUELINE K | Director | Grant | 1K | $0.00 | $0 | 27K |
| 2026-04-28 | O'Day Daniel Patrick | Chairman & CEO | Sell | 3K | $130.01 | $397K | 633K |
| 2026-04-28 | O'Day Daniel Patrick | Chairman & CEO | Sell | 7K | $128.79 | $895K | 636K |
| 2026-04-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3K | $140.96 | $423K | 129K |
| 2026-04-15 | Dickinson Andrew D | Chief Financial Officer | Sell | 3K | $140.96 | $423K | 176K |
| 2026-03-27 | O'Day Daniel Patrick | Chairman & CEO | Sell | 10K | $136.82 | $1.4M | 643K |
| 2026-03-16 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3K | $144.23 | $433K | 132K |
| 2026-03-16 | Dickinson Andrew D | Chief Financial Officer | Sell | 3K | $144.23 | $433K | 179K |
| 2026-03-10 | Berger Dietmar | Chief Medical Officer | Tax withholding | 1K | $148.56 | $158K | 19K |
| 2026-03-10 | Berger Dietmar | Chief Medical Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 20K |
| 2026-03-10 | O'Day Daniel Patrick | Chairman & CEO | Tax withholding | 10K | $148.56 | $1.5M | 653K |
| 2026-03-10 | O'Day Daniel Patrick | Chairman & CEO | Exercise or conversion | 20K | price not stated in the filing | not stated | 662K |
| 2026-03-10 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Exercise or conversion | 1K | price not stated in the filing | not stated | 6K |
| 2026-03-10 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Tax withholding | 606 | $148.56 | $90K | 5K |
| 2026-03-10 | Mercier Johanna | Chief Comm & Corp Aff Officer | Tax withholding | 3K | $148.56 | $478K | 135K |
| 2026-03-10 | Mercier Johanna | Chief Comm & Corp Aff Officer | Exercise or conversion | 7K | price not stated in the filing | not stated | 138K |
| 2026-03-10 | Dickinson Andrew D | Chief Financial Officer | Tax withholding | 3K | $148.56 | $468K | 182K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON48 Form 144 notices on file for GILD worth $96.3M at the prices reported; 9 in the last 90 days worth $16.7M. Latest: ANDREW DICKINSON filed on 2026-10-15 to sell 3,000 shares ($469K) from 2026-10-15.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-15 | ANDREW DICKINSONOfficer | 3K | $469K | 0.000% | 2026-10-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-10-15 | JOHANNA MERCIEROfficer | 3K | $469K | 0.000% | 2026-10-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-15 | ANDREW DICKINSONOfficer | 3K | $436K | 0.000% | 2026-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-15 | JOHANNA MERCIEROfficer | 3K | $433K | 0.000% | 2026-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-26 | ANTHONY WELTERSDirector | 18K | $2.7M | 0.001% | 2026-08-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-20 | JEFFREY BLUESTONEDirector | 5K | $738K | 0.000% | 2026-08-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | JOHANNA MERCIEROfficer | 28K | $3.9M | 0.002% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | ANDREW DICKINSONOfficer | 3K | $415K | 0.000% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-03 | DANIEL O'DAYDirector, Officer | 55K | $7.2M | 0.004% | 2026-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-15 | JOHANNA MERCIEROfficer | 3K | $390K | 0.000% | 2026-07-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-15 | ANDREW DICKINSONOfficer | 3K | $390K | 0.000% | 2026-07-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-15 | JOHANNA MERCIEROfficer | 3K | $372K | 0.000% | 2026-06-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-15 | ANDREW DICKINSONOfficer | 3K | $376K | 0.000% | 2026-06-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-01 | DANIEL O'DAYDirector, Officer | 35K | $4.7M | 0.003% | 2026-06-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-15 | JOHANNA MERCIEROfficer | 28K | $3.7M | 0.002% | 2026-05-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-15 | ANDREW DICKINSONOfficer | 3K | $397K | 0.000% | 2026-05-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-28 | DANIEL O'DAYOfficer, Director | 10K | $1.3M | 0.001% | 2026-04-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-15 | JOHANNA MERCIEROfficer | 3K | $423K | 0.000% | 2026-04-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-15 | ANDREW DICKINSONOfficer | 3K | $423K | 0.000% | 2026-04-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-27 | DANIEL O'DAYOfficer, Director | 10K | $1.4M | 0.001% | 2026-03-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-16 | JOHANNA MERCIEROfficer | 3K | $433K | 0.000% | 2026-03-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-16 | ANDREW DICKINSONOfficer | 3K | $433K | 0.000% | 2026-03-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-27 | DANIEL O'DAYOfficer, Director | 10K | $1.4M | 0.001% | 2026-02-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | JOHANNA MERCIEROfficer | 28K | $4.3M | 0.002% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | ANDREW DICKINSONOfficer | 3K | $463K | 0.000% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-05 | DANIEL O'DAYOfficer, Director | 116K | $17.3M | 0.009% | 2026-02-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-28 | DANIEL O'DAYOfficer, Director | 10K | $1.4M | 0.001% | 2026-01-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-23 | DANIEL O'DAYOfficer, Director | 116K | $15.6M | 0.009% | 2026-01-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-22 | DEBORAH TELMANOfficer | 29K | $3.8M | 0.002% | 2026-01-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-20 | JEFFREY BLUESTONEDirector | 5K | $618K | 0.000% | 2026-01-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-15 | JOHANNA MERCIEROfficer | 3K | $373K | 0.000% | 2026-01-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-15 | ANDREW DICKINSONOfficer | 3K | $373K | 0.000% | 2026-01-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | DANIEL O'DAYOfficer, Director | 10K | $1.2M | 0.001% | 2025-12-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-15 | JOHANNA MERCIEROfficer | 3K | $366K | 0.000% | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-15 | ANDREW DICKINSONOfficer | 3K | $366K | 0.000% | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-28 | DANIEL O'DAYOfficer, Director | 10K | $1.3M | 0.001% | 2025-11-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-28 | JEFFREY BLUESTONEDirector | 5K | $625K | 0.000% | 2025-11-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-26 | KELLY KRAMERDirector | 6K | $713K | 0.000% | 2025-11-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-17 | JOHANNA MERCIEROfficer | 28K | $3.5M | 0.002% | 2025-11-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-17 | ANDREW DICKINSONOfficer | 3K | $313K | 0.000% | 2025-11-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-13 | DIANE E WILFONGOfficer | 4K | $445K | 0.000% | 2025-11-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | DEBORAH TELMANOfficer | 56K | $6.8M | 0.004% | 2025-11-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-28 | DANIEL ODAYOfficer, Director | 10K | $1.2M | 0.001% | 2025-10-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-15 | JOHANNA MERCIEROfficer | 3K | $354K | 0.000% | 2025-10-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-15 | ANDREW DICKINSONOfficer | 3K | $295K | 0.000% | 2025-10-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-29 | DANIEL O'DAYOfficer, Director | 10K | $1.1M | 0.001% | 2025-09-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-15 | JOHANNA MERCIEROfficer | 3K | $341K | 0.000% | 2025-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-15 | ANDREW DICKINSONOfficer | 3K | $284K | 0.000% | 2025-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of GILD in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 7.5% of the class (93,327,127 shares), filed 2026-04-29 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 93.3M | 7.5% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 10 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-05 | 13G | FMR LLCparent holding company | 65.5M | 5.3% | 2025-12-31 |
| 2026-02-05 | 13G | Abigail P. Johnsonindividual | 65.5M | 5.3% | 2025-12-31 |
13F holders
Tracked managers holding GILD at their latest 13F. JSON9 of the 30 tracked managers held GILD at their latest 13F, $1.55B in total at quarter-end prices. Citadel Advisors is the largest at $439.7M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 7 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 3.5M | $439.7M | 0.05% | -502K |
| D. E. Shaw & Co. | 2026-06-30 | 2.3M | $289.9M | 0.14% | +2.1M |
| Renaissance Technologies | 2026-06-30 | 2.2M | $280.1M | 0.39% | +65K |
| Millennium Management | 2026-06-30 | 1.5M | $184.3M | 0.07% | +278K |
| Point72 Asset Management | 2026-06-30 | 1.4M | $181.6M | 0.20% | +1.4M |
| AQR Capital Management | 2026-06-30 | 695K | $86.9M | 0.03% | -469K |
| Two Sigma Investments | 2026-06-30 | 409K | $51.7M | 0.04% | +396K |
| Bridgewater Associates | 2026-06-30 | 291K | $36.7M | 0.15% | +110K |
| Fisher Asset Management | 2026-06-30 | 19K | $2.4M | 0.00% | +8K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Gilead Sciences reported revenue of $7.80B, up 10.2% from the same quarter a year earlier, and net loss of $10.50B (-8.45 diluted EPS). In FY 2025 it generated $10.02B of operating cash flow and spent $1.92B on buybacks and $4.00B on dividends.
- Debt
- $26.25B
- Equity
- $11.83B
- Total assets
- $49.36B
- Shares outstanding
- 1,239,955,155
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $7.80B | -$10.50B | -134.5% | -8.45 |
| Q1 FY 2026 | 2026-03-31 | $6.96B | $2.02B | 29.0% | 1.61 |
| Q4 FY 2025derived | 2025-12-31 | $7.92B | $2.18B | 27.5% | n/a |
| Q3 FY 2025 | 2025-09-30 | $7.77B | $3.05B | 39.3% | 2.43 |
| Q2 FY 2025 | 2025-06-30 | $7.08B | $1.96B | 27.7% | 1.56 |
| Q1 FY 2025 | 2025-03-31 | $6.67B | $1.31B | 19.7% | 1.04 |
| Q4 FY 2024derived | 2024-12-31 | $7.57B | $1.78B | 23.6% | n/a |
| Q3 FY 2024 | 2024-09-30 | $7.54B | $1.25B | 16.6% | 1.00 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $29.44B | $8.51B | $10.02B | $563.0M | $1.92B | $4.00B |
| FY 2024 | 2024-12-31 | $28.75B | $480.0M | $10.83B | $523.0M | $1.15B | $3.92B |
| FY 2023 | 2023-12-31 | $27.12B | $5.67B | $8.01B | $585.0M | $1.00B | $3.81B |
| FY 2022 | 2022-12-31 | $27.28B | $4.59B | $9.07B | $728.0M | $1.40B | $3.71B |
| FY 2021 | 2021-12-31 | $27.30B | $6.22B | $11.38B | $579.0M | $546.0M | $3.60B |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Gilead Sciences in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Gilead Sciences (GILD), SEC CIK 882095, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-15.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-15.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-29.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-04.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-15.JSON and CSV
- Company record
- EDGAR filing index for CIK 882095Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
Other company pages
Datasets
Frequently Asked Questions
How much of GILD is sold short?
20,270,007 shares were held short at the 2026-10-15 settlement, 3.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is GILD's daily short volume?
On 2026-10-28, 907,464 of the 1,715,140 GILD shares reported to FINRA were sold short, 52.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does GILD have fails to deliver?
The SEC's latest file shows 1,997 GILD shares failed to deliver at settlement 2026-09-15. Fails are reported per settlement date and published twice a month with a lag.
Are GILD insiders buying or selling?
Insiders at GILD reported 26 open-market sells worth $15.9M in the last 90 days and no open-market buys. Latest filing: Mercier Johanna (Chief Comm & Corp Aff Officer) on 2026-10-15.
Have GILD insiders filed to sell?
48 Form 144 notices on file for GILD worth $96.3M at the prices reported; 9 in the last 90 days worth $16.7M. Latest: ANDREW DICKINSON filed on 2026-10-15 to sell 3,000 shares ($469K) from 2026-10-15.
Who owns 5% or more of GILD?
3 holders report 5% or more of GILD in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 7.5% of the class (93,327,127 shares), filed 2026-04-29 for an event on 2026-03-31.
What did GILD report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Gilead Sciences reported revenue of $7.80B, up 10.2% from the same quarter a year earlier, and net loss of $10.50B (-8.45 diluted EPS). In FY 2025 it generated $10.02B of operating cash flow and spent $1.92B on buybacks and $4.00B on dividends.
Which tracked 13F managers own GILD?
9 of the 30 tracked 13F managers held GILD shares at their latest filing, $1.55B in all. The largest: Ken Griffin's Citadel Advisors (3.5M shares, $439.7M), D. E. Shaw & Co. (2.3M shares, $289.9M), Renaissance Technologies (2.2M shares, $280.1M), Izzy Englander's Millennium Management (1.5M shares, $184.3M), Steve Cohen's Point72 Asset Management (1.4M shares, $181.6M), Cliff Asness's AQR Capital Management (695K shares, $86.9M). The table above lists all 9.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.